Clinical Trials
14 trialsNCT06009627 2026-02-10
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Completed
NCT04431674 2023-12-13
USmBRT-B
Sunnybrook Health Sciences Centre
Phase 1 Completed
NCT05110170 2023-05-16
Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®
Luye Pharma Group Ltd.
Phase 3 Completed
NCT04382352 2023-03-24
B002-101
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 1 Completed
NCT05765357 2023-03-13
Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT05471648 2023-01-26
A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers
EirGenix, Inc.
Phase 1 Completed
NCT02652923 2023-01-23
Contrast Ultrasound Detection of Sentinel Lymph Nodes
Thomas Jefferson University
Phase 1/2 Completed
NCT03139851 2021-09-10
CHEMOIMMUNE
Centre Leon Berard
Phase 2 Completed
NCT02223052 2020-05-12
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Celgene
Phase 1 Completed
NCT01479244 2017-02-27
PRESENT
Galena Biopharma, Inc.
Phase 3 Completed
NCT02154139 2016-02-17
Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"
Takeda
Completed
NCT00918281 2014-06-09
Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection
GE Healthcare
Phase 2 Completed
NCT01765309 2013-01-14
A Randomized Controlled Trial To Evaluate The Use Of Botox In Breast Reconstruction With Tissue Expanders
University of Colorado, Denver
Phase NA Completed
NCT00041808 2005-06-24
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
FeRx
Phase 1/2 Completed